Search research articles
Contact Us
Filters
Showing results (41-50 of 78) with videos related to
Page
of 8
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
November 8, 2025
Radiotherapy for penile cancers: 2025 update
Geneviève Loos, Alexandre Escande, Sabrina Aziez, et al.
Cancer Treatment Reviews
|
October 29, 2015
Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU)
Paul Sargos, Stéphane Guerif, Igor Latorzeff, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
February 17, 2026
Erratum to "External beam radiotherapy for prostatic cancers: 2025 update" [Cancer Radiother 29 (2025) 104777]
Igor Latorzeff, Alizée Camps-Maléa, Christophe Hennequin, et al.
European Urology Oncology
|
August 28, 2023
Sexual Structure Sparing for Prostate Cancer Radiotherapy: A Systematic Review
Jennifer Le Guevelou, Paul Sargos, Ludovic Ferretti, et al.
European Urology
|
March 15, 2024
Long-term Outcomes and Patterns of Relapse Following High-dose Elective Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Nodes in Prostate Cancer: OLIGOPELVIS (GETUG-P07)
Loig Vaugier, Cyrille Morvan, David Pasquier, et al.
Clinical and Translational Radiation Oncology
|
December 19, 2023
Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer
Ingrid Masson, Laurène Larriviere, Marc-André Mahé, et al.
Frontiers in Oncology
|
January 28, 2022
Cost and Toxicity Comparisons of Two IMRT Techniques for Prostate Cancer: A Micro-Costing Study and Weighted Propensity Score Analysis Based on a Prospective Study
Ingrid Masson, Martine Bellanger, Geneviève Perrocheau, et al.
Radiation Oncology (London, England)
|
February 9, 2019
Is mean heart dose a relevant surrogate parameter of left ventricle and coronary arteries exposure during breast cancer radiotherapy: a dosimetric evaluation based on individually-determined radiation dose (BACCARAT study)
Sophie Jacob, Jérémy Camilleri, Sylvie Derreumaux, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 3, 2018
Daily Versus Weekly Prostate Cancer Image Guided Radiation Therapy: Phase 3 Multicenter Randomized Trial
Renaud de Crevoisier, Mohamed Amine Bayar, Pascal Pommier, et al.
BMC Cancer
|
April 18, 2015
Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: long term outcome of the Temporary Authorization for Use programme in France
Nadine Houédé, Philippe Beuzeboc, Sophie Gourgou, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 78) with videos related to
Sort By:
Page
of 8
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
November 8, 2025
Radiotherapy for penile cancers: 2025 update
Geneviève Loos, Alexandre Escande, Sabrina Aziez, et al.
Cancer Treatment Reviews
|
October 29, 2015
Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU)
Paul Sargos, Stéphane Guerif, Igor Latorzeff, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
February 17, 2026
Erratum to "External beam radiotherapy for prostatic cancers: 2025 update" [Cancer Radiother 29 (2025) 104777]
Igor Latorzeff, Alizée Camps-Maléa, Christophe Hennequin, et al.
European Urology Oncology
|
August 28, 2023
Sexual Structure Sparing for Prostate Cancer Radiotherapy: A Systematic Review
Jennifer Le Guevelou, Paul Sargos, Ludovic Ferretti, et al.
European Urology
|
March 15, 2024
Long-term Outcomes and Patterns of Relapse Following High-dose Elective Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Nodes in Prostate Cancer: OLIGOPELVIS (GETUG-P07)
Loig Vaugier, Cyrille Morvan, David Pasquier, et al.
Clinical and Translational Radiation Oncology
|
December 19, 2023
Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer
Ingrid Masson, Laurène Larriviere, Marc-André Mahé, et al.
Frontiers in Oncology
|
January 28, 2022
Cost and Toxicity Comparisons of Two IMRT Techniques for Prostate Cancer: A Micro-Costing Study and Weighted Propensity Score Analysis Based on a Prospective Study
Ingrid Masson, Martine Bellanger, Geneviève Perrocheau, et al.
Radiation Oncology (London, England)
|
February 9, 2019
Is mean heart dose a relevant surrogate parameter of left ventricle and coronary arteries exposure during breast cancer radiotherapy: a dosimetric evaluation based on individually-determined radiation dose (BACCARAT study)
Sophie Jacob, Jérémy Camilleri, Sylvie Derreumaux, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 3, 2018
Daily Versus Weekly Prostate Cancer Image Guided Radiation Therapy: Phase 3 Multicenter Randomized Trial
Renaud de Crevoisier, Mohamed Amine Bayar, Pascal Pommier, et al.
BMC Cancer
|
April 18, 2015
Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: long term outcome of the Temporary Authorization for Use programme in France
Nadine Houédé, Philippe Beuzeboc, Sophie Gourgou, et al.
Page
of 8